Calcitonin treatment effectively reduced the Ca2+ content in the serum samples and prefrontal cortical tissues of CKD mice, while overexpression of Drp1 did not affect the suppressive effect of calcitonin on the Ca2+ content in serum and cortical tissues (Fig. 3A, B). The gene discussed is CALCA; the disease is chronic kidney disease.